Products for Research Use Only
RegisterLogin

Galcanezumab

CAT: 0804-HY-P99021-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99021-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Galcanezumab (LY 2951742) is a humanized IgG4 monoclonal antibody against the CGRP ligand. Galcanezumab can be used for migraine or cluster headaches research[1].
CAS Number
1578199-75-3
Product Name Alternative
LY 2951742
UNSPSC
12352203
Target
CGRP Receptor
Type
Inhibitory Antibodies
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/galcanezumab.html
Purity
98.00
Solubility
H2O
Smiles
[Galcanezumab]
Molecular Weight
(145.5 kDa)
References & Citations
[1]Yvette N Lamb. Galcanezumab: First Global Approval. Drugs. 2018 Nov;78 (16) :1769-1775.|[2]Hashikawa-Hobara N, et al., Lack of alpha CGRP exacerbates the development of atherosclerosis in ApoE-knockout mice. Sci Rep. 2024 Aug 8;14 (1) :18377.|[3]Benschop RJ, et al., Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain. Osteoarthritis Cartilage. 2014 Apr;22 (4) :578-85.
Shipping Conditions
Blue Ice
Storage Conditions
Store at 4°C for 2 years, do not freeze
Scientific Category
Inhibitory Antibodies
Clinical Information
Launched

Alternative Products

CatalogName
abx831382-01Galcanezumab
HY028016-01Research Grade Galcanezumab
E55B0736Galcanezumab (Reference antibody)
ICH5046-25mgGalcanezumab Biosimilar - Research Grade
A2577-1mgGalcanezumab (Anti-CALCA / CGRP)
ABS-162-1mgGalcanezumab Biosimilar, Research Grade
KBI1347KRIBIOLISA™ Galcanezumab (EMGALITY) ELISA

Popular Products